Omega Therapeutics Appoints New Chief Business Officer
Company Announcements

Omega Therapeutics Appoints New Chief Business Officer

Omega Therapeutics (OMGA) just unveiled an update.

Kaan Certel, Ph.D., with over two decades of experience in the biopharmaceutical sector, has been appointed as the new Chief Business Officer of the Company. Starting May 28, 2024, he will spearhead the company’s global business development and strategic partnerships.

Find detailed analytics on OMGA stock on TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskOmega Therapeutics Welcomes Robert Rosiello to Board
TheFlyOmega Therapeutics announces publication of preclinical data of OTX-2002
TheFlyOmega Therapeutics appoints Nelson as SVP of Research
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App